International Journal of Advanced and Integrated Medical Sciences

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  3 (2018)
Volume  2 (2017)
Volume  1 (2016)
Related articles

VOLUME 2 , ISSUE 4 ( 2017 ) > List of Articles

ORIGINAL ARTICLE

Clinical Profile of Refractive Errors in School-going Children of Bareilly, Uttar Pradesh, India

Ritu Jain, Juhi Mittal, Yusuf Rizvi

Keywords : Refractive errors, School-going children

Citation Information : Jain R, Mittal J, Rizvi Y. Clinical Profile of Refractive Errors in School-going Children of Bareilly, Uttar Pradesh, India. Int J Adv Integ Med Sci 2017; 2 (4):169-172.

DOI: 10.5005/jp-journals-10050-10098

License: CC BY-SA 4.0

Published Online: 01-06-2018

Copyright Statement:  Copyright © 2017; The Author(s).


Abstract

Introduction Refractive error is one of the important causes of impaired visual acuity in children. Aim To study the pattern of refractive errors in children of Bareilly city and determine its association with selected variables of age, sex, educational status, socioeconomic status, residing locality, family history, previous use of spectacles, amblyopia, and strabismus. Materials and methods A cross-sectional study was conducted on 521 children aged 5 to 15 years attending the ophthalmology outpatient department (OPD) of a teaching hospital of Bareilly. Visual status along with dry and cycloplegic refraction was carried out. Relevant data in relation to the selected variables were compiled. Statistical analysis of obtained results was carried out using the software Statistical Package for the Social Sciences (SPSS) version 22. Results The mean age of presentation of refractive error was 10.75 ± 2.96 years with a distinct male preponderance and with a male:female ratio of 1.33:1. Parental education background revealed fair literacy rate with 56.23% mothers and 69.28% fathers having intermediate qualification and above. Higher incidence of refractive error was noted in children with upper lower socioeconomic status (34.54%) and with those having positive family history (61.23%); 7.67% children were amblyopic and 7.10% children had coexisting strabismus. Most of the children (80.23%) gave no history of previous use of spectacles. Astigmatism was noted as the commonest refractive error in 45.09% followed by myopia (42.86%) and hypermetropia (12.05%). Conclusion The study provides an insight into the quantum, extent, and form of visual impairment prevalent in Bareilly district. It furnishes essential data for planning and evaluating preventive and curative services for visual impairment of children in this region. Clinical significance These data support the assumption that vision screening of achool children in developing countries would be very useful in early detection of correctable causes of poor vision, especially refractive errors and in preventingvisual complications. How to cite this article Mittal J, Rizvi Y, Jain R. Clinical Profile of Refractive Errors in School-going Children of Bareilly, Uttar Pradesh, India. Int J Adv Integ Med Sci 2017;2(4):169-172.

PDF Share
  1. Resnikoff S, Pascolini D, Mariotti SP, Pokharel GP. Global magnitude of visual impairment caused by uncorrected refractive errors in 2004. Bull World Health Organ 2008 Jan;86(1):63-70.
  2. Padhye AS, Khandekar R, Dharmadhikari S, Dole K, Gogate P, Deshpande M. Prevalence of uncorrected refractive error and other eye problems among urban and rural school children. Middle East Afr J Ophthalmol 2009 Apr-Jun;16(2):69-74.
  3. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol 2012 May;96(5):614-618.
  4. Kalikivayi V, Naduvilath TJ, Bansal AK, Dandona L. Visual impairment in school children in southern India. Indian J Ophthalmol 1997 Jun;45(2):129-134.
  5. Wu JF, Bi HS, Wang SM, Hu YY, Wu H, Sun W, Lu TL, Wang XR, Jonas JB. Refractive error, visual acuity and causes of vision loss in children in Shangdon, China. The Shangdon Children Eye Study. PLoS One 2013 Dec;8(12):e82763.
  6. Yamamah GA, Talaat Abdel Alim AA, Mostafa YS, Ahmed RA, Mahmoud AM. Prevalence of visual impairment and refractive errors in children of South Sinai, Egypt. Ophthalmic Epidemiol 2015 Aug;22(4):246-252.
  7. Rai S, Thapa HB, Sharma MK, Dhakhwa K, Karki R. The distribution of refractive errors among children attending Lumbini Eye Institute, Nepal. Nepal J Ophthalmol 2012 Jan-Jun;4(7):90-95.
  8. Alam M, Fareed M. Refractive errors; profile in school age children. Professional Med J 2011 Oct-Dec;18(4):649-653.
  9. Sethi MJ, Sethi S, Iqbal R. Frequency of refractive error in children visiting outpatient department agency Headquarter Hospital Landi Kotil. Gomal J Med Sci 2009 Jul-Dec;7(2):114-117.
  10. Matta S, Matta P, Gupta V, Dev V. Refractive errors among adolescents attending ophthalmology OPD. Indian J Community Med 2006 Apr-Jun;31(2):114-115.
  11. Rohul J, Maqbool A, Hussain SA, Shamila H, Anjum F, Hamdani ZA. Prevalence of refractive errors in adolescents in out-patient attendees of the preventive ophthalmology clinic of community medicine, S K I M S, Kashmir, India. NUJHS 2013 Mar;3(1):17-20.
  12. Sethi S, Sethi MJ, Hussain I, Khan T. Refractive errors in children attending out- patient department of ophthalmology, Khyber Teaching Hospital, Peshawar. Pak J Ophthalmol 2008 Dec;4:1-5.
  13. Mehari ZA. Pattern of childhood ocular morbidity in rural eye hospital, Central Ethiopia. BMC Ophthalmol 2014 Apr;14(1):50.
  14. Shrestha GS, Sujakhu D, Joshi P. Refractive error among school children in Jhapa, Nepal. J Optom 2011 Apr;4(2):49-55.
  15. Pavithra MB, Maheshwaran R, Rani Sujatha MA. A study on the prevalence of refractive errors among school children of 7-15 years age group in the field practice areas of a medical college in Bangalore. Int J Med Sci Public Health 2013 Jan;2(3):641-645.
  16. Ali A, Ahmad I, Ayub S. Prevalence of undetected refractive errors among school children. E:/Biomedica 2007 Jul-Dec;23(Bio 21):96-101.
  17. Batra N, Kaushal D, Gill AS. Refractive errors in school children: a review from Punjab. NPCB India 2007 Oct-Dec;1(4):2-4.
  18. Murthy GV, Gupta SK, Ellwein LB, Munoz SR, Pokharel GP, Sanga L, Bachani D. Refractive error in children in an urban population in New Delhi. Invest Ophthalmol Vis Sci 2002 Mar;43(3):623-631.
  19. Pant BP, Ghising R, Awasthi S, Pant SR, Bhatta RC. Refractive status among the students presenting to Geta Eye Hospital, Kailali, Nepal. Nepal Med Coll J 2010 Jun;12(2):95-99.
  20. Lindelof B, Islam N, Eklund G, Arfors L. Pemphigoid and cancer. Arch Dermatol 1990 Jan;126(1):66-68.
  21. Dahl MV, Ristow S. Bullous pemphigoid and ovarian cystadenocarcinoma: immunologic studies. Arch Dermatol 1978 Jun;114(6):903-905.
  22. Daoud, MS.; Pittelkow, MR. Pityriasis lichenoides. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB, editors. Fitzpatrick's dermatology in general medicine. 5th ed. New York: McGraw-Hill; 1999. pp. 553-560.
  23. Litt, JZ. Drug eruption reference manual. New York: Parthenon Publishing; 1998. p. 564.
  24. Tosi A, Misciali C, Piraccini B, Peluso AM, Bardazzi F. Drug-induced hair loss and hair growth. Incidence, management and avoidance. Drug Saf 1994 Apr;10(4):310-317.
  25. Bronner AK, Hood AF. Cutaneous complication of chemotherapeutic agents. J Am Acad Dermatol 1983 Nov;9(5):645-663.
  26. Hood AF. Cutaneous side effects of cancer chemotherapy. Med Clin North Am 1986 Jan;70(1):187-209.
  27. Boyle DM, Engelking C. Vesicant extravasation: myths and realities. Oncol Nurs Forum 1995 Jan-Feb;22(1):57-67.
  28. Malkinson, FD. Radiobiology of the skin. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB, editors. Fitzpatrick's dermatology in general medicine. 5th edn. New York: McGraw-Hill; 1999. pp. 1514-1523.
  29. Goldschmidt H, Breneman JC, Bareneman DL. Ionizing radiation therapy in dermatology. J Am Acad Dermatol 1994 Feb;30(2 Pt 1):157-182.
  30. Narkiewicz K, van de Borne P, Montano N, Hering D, Kara T, Somers VK. Sympathetic neural outflow and chemoreflex sensitivity are related to spontaneous breathing rate in normal men. Hypertension 2006;47(1):51-55.
  31. Agte VV, Chiplonkar SA. Sudarshan kriya yoga for improving antioxidant status and reducing anxiety in adults. Altern Complement Ther 2008;14(2):96-100.
  32. Jacobs GD. Clinical applications of the relaxation response and mind-body interventions. J Altern Complement Med 2001;7(Suppl 1):S93-S101.
  33. Singh N, Telles S. Heart rate variability and state anxiety in hypertensives and diabetes after one week of yoga. J Indian Psychol 2009;27(1-2):13-20.
  34. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, Sever PS, McG Thom S; British Hypertension Society. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV. J Hum Hypertens 2004 Mar;18(3):139-185.
  35. Rabi DM, Daskalopoulou SS, Padwal RS, Khan NA, Grover SA, Hackam DG, Myers MG, McKay DW, Quinn RR, Hemmelgarn BR, et al. The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 2011 Jul-Aug;27(4):415-433.e1-2.
  36. Wahlgren NG, MacMahon DG, De Keyser JF, Indredavik B, Ryman T. Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke. Cerebrovasc Dis 1994 May;4(3):204-10.
  37. Kaste M, Fogelholm R, Erilä T, Palomäki H, Murros K, Rissanen A, Sarna S. A randomized, double-blind, placebo-controlled trial of nimodipine in acute ischemic hemispheric stroke. Stroke 1994 Jul;25(7):1348-1353.
  38. Schrader J, Lüders S, Kulschewski A, Berger J, Zidek W, Treib J, Einhaupl K, Diener HC, Dominiak P; Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group. The ACCESS study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 2003 Jul;34(7):1699-1703.
  39. Sandset EC, Bath PM, Boysen G, Jatuzis D, Kõrv J, Lüders S, Murray GD, Richter PS, Roine RO, Terént A, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet 2011 Feb;377(9767):741-750.
  40. Potter JF, Robinson TG, Ford GA, Mistri A, James M, Chernova J, Jagger C. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol 2009 Jan;8(1):48-56.
  41. Robinson TG, Potter JF, Ford GA, Bulpitt CJ, Chernova J, Jagger C, James MA, Knight J, Markus HS, Mistri AK, et al. Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol 2010 Aug;9(8):767-775.
  42. Jauch EC, Saver JL, Adams HP, Bruno A, Demaerschalk BM, Khatri P, McMullan PW, Qureshi AI, Rosenfield K, Scott PA, et al. Guidelines for the early management of patients with acute ischemic stroke. Stroke 2013 Mar;44(3):870-947.
  43. Ahmed N, Wahlgren N, Brainin M, Castillo J, Ford GA, Kaste M, Lees KR, Toni D; SITS Investigators. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis. Stroke 2009 Jul;40(7):2442-2449.
  44. Karachalios GN, Charalabopoulos A, Papalimneou V, Kiortsis D, Dimicco P, Kostoula OK, Charalabopoulos K. Withdrawal syndrome following cessation of antihypertensive drug therapy. Int J Clin Pract 2005 May;59(5):562-570.
  45. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001 Sep;358(9287):1033-1041.
  46. Schrader J, Lüders S, Kulschewski A, Hammersen F, Plate K, Berger J, Zidek W, Dominiak P, Diener HC; MOSES Study Group. Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention. Stroke 2005 Jun;36(6):1218-1226.
  47. Yusuf S, Diener HC, Sacco RL, Cotton D, Ôunpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, et al. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med 2008 Sep;359(12):1225-1237.
  48. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 2014 Jan:45(7):2160-2236.
  49. Robb AO, Mills NL, Din JN, Smith IB, Paterson F, Newby DE, Denison FC. Influence of the menstrual cycle, pregnancy, and preeclampsia on arterial stiffness. Hypertension 2009 Jun;53(6):952-958.
  50. Avni B, Frenkel G, Shahar L, Golik A, Sherman D, Dishy V. Aortic stiffness in normal and hypertensive pregnancy. Blood Press 2010 Feb;19(1):11-15.
  51. Khalil A, Akolekar R, Syngelaki A, Elkhouli M, Nicolaides KH. Maternal hemodynamics at 11–13 weeks’ gestation and risk of pre-eclampsia. Ultrasound Obstet Gynecol 2012 Jul;40(1):28-34.
  52. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ 1992 Feb;304(6824):405-412.
  53. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, Faire U, Fyhrquist F, Ibsen H, Kristiansson K, Lederballe-Pedersen O, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002 Mar;359(9311):995-1003.
  54. Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trials-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005 Sep;366(9489):895-906.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.